Publication | Closed Access
Low-density lipoprotein cholesterol reduction by SCH 58235 (ezetimibe), a novel inhibitor of intestinal cholesterol absorption in 243 hypercholesteremic subjects: Results of a dose-response study
20
Citations
0
References
2000
Year
Lipid DisorderPharmacologyDose-response StudyHyperlipidemiaDyslipidemiaLipoprotein MetabolismMedicineSch 58235AtherosclerosisIntestinal Cholesterol Absorption
No additional data available for this publication yet. Check back later!